StonvexLoading…
StonvexStonvexStonvexCore line items from SLB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-24 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $8.77B | $8.72B | $35.71B | $25.96B | $17.04B |
Operating Income | Not available | $956.00M | $4.29B | $3.35B | $2.35B |
Net Income | Not available | $752.00M | $3.37B | $2.55B | $1.81B |
EPS (Diluted) | $0.52 | $0.50 | $2.35 | $1.80 | $1.32 |
Total Assets | Not available | $54.53B | $54.87B | $55.09B | $48.77B |
Total Liabilities | Not available | $27.17B | $27.58B | $28.17B | $27.22B |
Cash & Equivalents | Not available | $2.82B | $3.04B | $3.01B | $3.24B |
Free Cash Flow OCF − CapEx | Not available | $144.00M | $4.79B | $2.31B | $1.03B |
Shares Outstanding | Not available | 1.50B | 1.50B | 1.41B | 1.37B |